Source: International Congress 2018 – Pharmacological management of COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Calverley (Aintree, United Kingdom), C. Page (London, United Kingdom), R. Dal Negro (Verona, Italy), G. Fontana (Firenze, Italy), M. Iversen (Copenhagen, Denmark), A. Cicero (Bologna, Italy), E. Pozzi (Paderno Dugnano, Italy), J. Wedzicha (London, United Kingdom). Effect of erdosteine in moderately severe COPD patients. 776

Member's Comments

No comment yet.

Related content which might interest you: The effect of long-term treatment with erdosteine on moderate or severe COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 292s Year: 2005 The effects of adding in erdosteine on the routine bronchodilator therapy in moderate and severe COPD patients Source: Annual Congress 2006 - COPD therapy Year: 2006 Effects of roflumilast in highly symptomatic COPD patients Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care Year: 2012 Effects of high dose N-acetylcysteine in COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Long-term effect of roflumilast on exacerbations in patients with severe to very severe COPD Source: Eur Respir J 2006; 28: Suppl. 50, 526s Year: 2006 Effect of roflumilast in patients with severe COPD and a history of hospitalisation Source: Eur Respir J, 50 (1) 1700158; 10.1183/13993003.00158-2017 Year: 2017 Effects of exercise in patients with moderate to severe asthma Source: Annual Congress 2008 - Risk factors for asthma versus asthma control Year: 2008 Impact of moderate and severe exacerbations in severe COPD patients Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Effect of azithromycin treatment on inflammation in COPD patients Source: International Congress 2019 – COPD clinical trials: inhaled and oral therapies Year: 2019 Effect of dupilumab on severe exacerbations in asthma patients with and without lung function improvements Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma Year: 2020 Effects of bosentan in patients with severe pulmonary hypertension and mild-to-moderate COPD Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Effects of Hochuekkito combined with pulmonary rehabilitation in patients with COPD Source: International Congress 2017 – Latest insights into pulmonary rehabilitation in COPD Year: 2017 Characterization of patients with severe COPD Source: International Congress 2018 – COPD around the world Year: 2018 Long-term use of antioxidant mucolytic erdosteine is especially beneficial in patients with more severe COPD Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Anti-oxidant effects of erdosteine in current smokers with mild COPD Source: Eur Respir J 2006; 28: Suppl. 50, 429s Year: 2006 Siccine acid effects in patients with exacerbation of severe COPD Source: Annual Congress 2007 - New insights into the treatment of COPD Year: 2007 Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020 Effect of simvastatin on pulmonary hypertension in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 287s Year: 2007 Effects of lisinipril on hypertensive COPD and asthma patients Source: Eur Respir J 2005; 26: Suppl. 49, 718s Year: 2005 Effect of roflumilast on hospitalizations in COPD patients Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012